Axtria to build industry's largest pharma-specific AI engineering team, scaling to 1,000 by Dec 2026

image credit- freepik

US-based Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, has announced plans to expand its Forward Deployed Engineering (FDE) organisation to 1,000 engineers by December 2026, creating the industry's largest pharma-specific AI engineering team.

The expansion represents one of Axtria's largest investments in AI talent development to date and reflects growing customer demand for engineers who can deploy, scale, and operationalise enterprise AI across commercial, medical, and market access functions.

Launched approximately 12 months ago, Axtria's Forward Deployed Engineering model was built on a simple premise: the future of AI in life sciences will be determined not by who has access to the best models, but by who can successfully deploy AI into complex enterprise environments and deliver measurable business outcomes. Today, Axtria's FDEs are embedded within leading life sciences organizations, deploying production-grade AI solutions across commercial and medical operations.

Building on this momentum, Axtria is expanding the organisation to 1,000 engineers by December 2026 through a combination of internal talent development and strategic hiring.

Through the Axtria Institute, the company is developing life sciences domain experts into certified AI engineers who deploy solutions across Industry leading platforms and Axtria's proprietary platforms—including SalesIQ™, MarketingIQ™ and DataMAx™, helping clients modernise data foundations, improve decision-making, and scale enterprise AI with strong governance and cost efficiency.